The impact of secondary infections in COVID-19 critically ill patients

Affiliations

¹ Department of Biomedical Sciences, Clinical Metabolomics Unit, University of Cagliari, Cagliari, Italy. Electronic address: federica.murgia@unica.it.
² Clinical-Chemical Analysis and Microbiology Laboratory, "San Francesco" Hospital, Nuoro, Italy.
³ Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy; Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Cagliari, Italy.
⁴ Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Cagliari, Italy.
⁵ Department of Biomedical Sciences, Clinical Metabolomics Unit, University of Cagliari, Cagliari, Italy.
⁶ Intensive Care Unit, "San Francesco" Hospital, Nuoro, Italy.
⁷ Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
⁸ Medical epidemiologist, WHO consultant, Geneva, Switzerland.
⁹ Department of Cellular, Computational and Integrative Biology, Center of Medical Sciences (CISMed), University of Trento, Trento Italy.

PMID: 35314266
PMCID: PMC8933050
DOI: 10.1016/j.jinf.2022.03.017

Comment

The impact of secondary infections in COVID-19 critically ill patients

Federica Murgia et al. J Infect. 2022 Jun.

. 2022 Jun;84(6):e116-e117.

doi: 10.1016/j.jinf.2022.03.017. Epub 2022 Mar 18.

Authors

Affiliations

¹ Department of Biomedical Sciences, Clinical Metabolomics Unit, University of Cagliari, Cagliari, Italy. Electronic address: federica.murgia@unica.it.
² Clinical-Chemical Analysis and Microbiology Laboratory, "San Francesco" Hospital, Nuoro, Italy.
³ Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy; Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Cagliari, Italy.
⁴ Multiple Sclerosis Center, Binaghi Hospital, ATS Sardegna, ASSL Cagliari, Cagliari, Italy.
⁵ Department of Biomedical Sciences, Clinical Metabolomics Unit, University of Cagliari, Cagliari, Italy.
⁶ Intensive Care Unit, "San Francesco" Hospital, Nuoro, Italy.
⁷ Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
⁸ Medical epidemiologist, WHO consultant, Geneva, Switzerland.
⁹ Department of Cellular, Computational and Integrative Biology, Center of Medical Sciences (CISMed), University of Trento, Trento Italy.

PMID: 35314266
PMCID: PMC8933050
DOI: 10.1016/j.jinf.2022.03.017

No abstract available

Keywords: Blood chemistry parameters; COVID-19; Clinical outcome; Microbiological data; SARS-CoV-2 infection; Secondary infections.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors have no competing interests to declare.

Comment in

Prognostic value of maximum NEWS-2 scores in addition to ISARIC 4C scores for patients admitted to hospital with COVID-19.
Akbar S, Pan D, Ehdode A, Islam R, Abouzaid A, Balasundaram K, Shihadeh M, Patel K, Othman G, Umerah O, Sze S, Nicoara DC, Woltmann G, Tang JW. Akbar S, et al. J Infect. 2022 Jul;85(1):e30-e32. doi: 10.1016/j.jinf.2022.04.013. Epub 2022 Apr 7. J Infect. 2022. PMID: 35398403 Free PMC article. No abstract available.
The risk of methicillin-resistant Staphylococcus aureus infection following COVID-19 and influenza: A retrospective cohort study from the TriNetX network.
Tsai YW, Tsai CF, Wu JY, Huang PY, Liu TH, Lai CC. Tsai YW, et al. J Infect. 2023 Mar;86(3):256-308. doi: 10.1016/j.jinf.2023.01.006. Epub 2023 Jan 9. J Infect. 2023. PMID: 36632945 Free PMC article. No abstract available.

Comment on

Co-infections in people with COVID-19: a systematic review and meta-analysis.
Lansbury L, Lim B, Baskaran V, Lim WS. Lansbury L, et al. J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27. J Infect. 2020. PMID: 32473235 Free PMC article.

References

1. Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81:266–275. - PMC - PubMed
1. Zhang G., Hu C., Luo L., Fang F., Chen Y., Li J., et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J ClinVirol. 2020;127 - PMC - PubMed
1. Hendaus M.A., Jomha F.A. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn. 2021;39:4185–4191. - PubMed
1. Rawson T.M., Wilson R.C., Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27:9–11. - PMC - PubMed
1. Musuuza J.S., Watson L., Parmasad V., Putman-Buehler N., Christensen L., Safdar N. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE. 2021;16 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The impact of secondary infections in COVID-19 critically ill patients

Affiliations

The impact of secondary infections in COVID-19 critically ill patients

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous